Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| ICU Medical Inc. | 0990-7965 | INTRAVENOUS | 21 mg in 100 mL | 7/13/2021 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| LYPHOLYTE MULTI-ELECTROLYTE CONC INJ | lyphomed, division of fujisawa canada inc. | 01944940 | Liquid - Intravenous | 43 MG / ML | 12/31/1991 |
| PLASMA-LYTE 56 5% DEXTROSE INJ | baxter corporation | 00260584 | Liquid - Intravenous | 32 MG / 100 ML | 12/31/1990 |
| LYPHOLYTE | Pharmaceutical Partners Of Canada Inc | 02139618 | Solution - Intravenous | 860 MG / 20 ML | 8/14/1996 |
| HYPERLYTE (MULTI-ELECTROLYTE CONCENTRATE) | b. braun medical inc | 01963910 | Liquid - Intravenous | 860 MG / 25 ML | 9/4/1998 |
| AMINOSYN 3.5% M | ABBOTT LABORATORIES, LIMITED | 00510629 | Liquid - Intravenous | 21 MG / 100 ML | 12/31/1980 |
| NORMOSOL-M & 5% DEXTROSE | ICU Medical Canada Inc | 00039489 | Solution - Intravenous | 0.021 G / 100 ML | 12/31/1965 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.